MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 527658 | Name: 2,4-PDCA

Description:

WARNING: This product is for research use only, not for human or veterinary use.

2,4-PDCA is a potent inhibitor of several Jumonji domain-containing lysine demethylases.

Chemical Structure

2,4-PDCA
CAS#499-80-9

Theoretical Analysis

MedKoo Cat#: 527658

Name: 2,4-PDCA

CAS#: 499-80-9

Chemical Formula: C7H5NO4

Exact Mass: 167.0219

Molecular Weight: 167.12

Elemental Analysis: C, 50.31; H, 3.02; N, 8.38; O, 38.29

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
2,4PDCA; 2,4 PDCA; 2,4-PDCA
IUPAC/Chemical Name
2,4-Pyridinedicarboxylic acid
InChi Key
MJIVRKPEXXHNJT-UHFFFAOYSA-N
InChi Code
InChI=1S/C7H5NO4/c9-6(10)4-1-2-8-5(3-4)7(11)12/h1-3H,(H,9,10)(H,11,12)
SMILES Code
O=C(C1=NC=CC(C(O)=O)=C1)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 167.12 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Mishur RJ, Khan M, Munkácsy E, Sharma L, Bokov A, Beam H, Radetskaya O, Borror M, Lane R, Bai Y, Rea SL. Mitochondrial metabolites extend lifespan. Aging Cell. 2016 Apr;15(2):336-48. doi: 10.1111/acel.12439. Epub 2016 Jan 5. PubMed PMID: 26729005; PubMed Central PMCID: PMC4783347. 2: Korczynska M, Le DD, Younger N, Gregori-Puigjané E, Tumber A, Krojer T, Velupillai S, Gileadi C, Nowak RP, Iwasa E, Pollock SB, Ortiz Torres I, Oppermann U, Shoichet BK, Fujimori DG. Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors. J Med Chem. 2016 Feb 25;59(4):1580-98. doi: 10.1021/acs.jmedchem.5b01527. Epub 2015 Dec 23. PubMed PMID: 26699912; PubMed Central PMCID: PMC5080985. 3: Qi H, Jing Z, Xiaolin W, Changwu X, Xiaorong H, Jian Y, Jing C, Hong J. Histone Demethylase JMJD2A Inhibition Attenuates Neointimal Hyperplasia in the Carotid Arteries of Balloon-Injured Diabetic Rats via Transcriptional Silencing: Inflammatory Gene Expression in Vascular Smooth Muscle Cells. Cell Physiol Biochem. 2015;37(2):719-34. doi: 10.1159/000430390. Epub 2015 Sep 11. PubMed PMID: 26356263. 4: Horita S, Scotti JS, Thinnes C, Mottaghi-Taromsari YS, Thalhammer A, Ge W, Aik W, Loenarz C, Schofield CJ, McDonough MA. Structure of the ribosomal oxygenase OGFOD1 provides insights into the regio- and stereoselectivity of prolyl hydroxylases. Structure. 2015 Apr 7;23(4):639-52. doi: 10.1016/j.str.2015.01.014. Epub 2015 Feb 26. PubMed PMID: 25728928; PubMed Central PMCID: PMC4396695. 5: Sham A, Martinez EC, Beyer S, Trau DW, Raghunath M. Incorporation of a prolyl hydroxylase inhibitor into scaffolds: a strategy for stimulating vascularization. Tissue Eng Part A. 2015 Mar;21(5-6):1106-15. doi: 10.1089/ten.TEA.2014.0077. Epub 2015 Jan 14. PubMed PMID: 25370818; PubMed Central PMCID: PMC4356217. 6: An X, Wang H, Li G. Structures and Luminescent Properties of Two 2D Coordination Polymers Containing Tb(III) or Dy(III) Ions. J Fluoresc. 2014 Mar;24(2):425-9. doi: 10.1007/s10895-013-1308-5. Epub 2013 Oct 5. PubMed PMID: 24091805. 7: Hopkinson RJ, Tumber A, Yapp C, Chowdhury R, Aik W, Che KH, Li XS, Kristensen JBL, King ONF, Chan MC, Yeoh KK, Choi H, Walport LJ, Thinnes CC, Bush JT, Lejeune C, Rydzik AM, Rose NR, Bagg EA, McDonough MA, Krojer T, Yue WW, Ng SS, Olsen L, Brennan PE, Oppermann U, Muller-Knapp S, Klose RJ, Ratcliffe PJ, Schofield CJ, Kawamura A. 5-Carboxy-8-hydroxyquinoline is a Broad Spectrum 2-Oxoglutarate Oxygenase Inhibitor which Causes Iron Translocation. Chem Sci. 2013 Aug 1;4(8):3110-3117. doi: 10.1039/C3SC51122G. PubMed PMID: 26682036; PubMed Central PMCID: PMC4678600. 8: Sayegh J, Cao J, Zou MR, Morales A, Blair LP, Norcia M, Hoyer D, Tackett AJ, Merkel JS, Yan Q. Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen. J Biol Chem. 2013 Mar 29;288(13):9408-17. doi: 10.1074/jbc.M112.419861. Epub 2013 Feb 13. PubMed PMID: 23408432; PubMed Central PMCID: PMC3611010. 9: Schley G, Klanke B, Schödel J, Kröning S, Türkoglu G, Beyer A, Hagos Y, Amann K, Burckhardt BC, Burzlaff N, Eckardt KU, Willam C. Selective stabilization of HIF-1α in renal tubular cells by 2-oxoglutarate analogues. Am J Pathol. 2012 Nov;181(5):1595-606. doi: 10.1016/j.ajpath.2012.07.010. Epub 2012 Aug 31. PubMed PMID: 22944601. 10: Hagos Y, Schley G, Schödel J, Krick W, Burckhardt G, Willam C, Burckhardt BC. α-Ketoglutarate-related inhibitors of HIF prolyl hydroxylases are substrates of renal organic anion transporters 1 (OAT1) and 4 (OAT4). Pflugers Arch. 2012 Oct;464(4):367-74. Epub 2012 Aug 9. PubMed PMID: 22875277. 11: Rakić GM, Grgurić-Šipka S, Kaluđerović GN, Bette M, Filipović L, Aranđelović S, Radulović S, Tešić ZLj. The synthesis, spectroscopic, X-ray characterization and in vitro cytotoxic testing results of activity of five new trans-platinum(IV) complexes with functionalized pyridines. Eur J Med Chem. 2012 Sep;55:214-9. doi: 10.1016/j.ejmech.2012.07.019. Epub 2012 Jul 22. PubMed PMID: 22858225. 12: Kristensen LH, Nielsen AL, Helgstrand C, Lees M, Cloos P, Kastrup JS, Helin K, Olsen L, Gajhede M. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor. FEBS J. 2012 Jun;279(11):1905-14. doi: 10.1111/j.1742-4658.2012.08567.x. Epub 2012 May 2. PubMed PMID: 22420752. 13: Gligorijević N, Aranđelović S, Filipović L, Jakovljević K, Janković R, Grgurić-Šipka S, Ivanović I, Radulović S, Tešić ZLj. Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure. J Inorg Biochem. 2012 Mar;108:53-61. doi: 10.1016/j.jinorgbio.2011.12.002. Epub 2011 Dec 16. PubMed PMID: 22266461. 14: Hutchinson SE, Leveridge MV, Heathcote ML, Francis P, Williams L, Gee M, Munoz-Muriedas J, Leavens B, Shillings A, Jones E, Homes P, Baddeley S, Chung CW, Bridges A, Argyrou A. Enabling lead discovery for histone lysine demethylases by high-throughput RapidFire mass spectrometry. J Biomol Screen. 2012 Jan;17(1):39-48. doi: 10.1177/1087057111416660. Epub 2011 Aug 21. PubMed PMID: 21859681. 15: Lushnikova I, Orlovsky M, Dosenko V, Maistrenko A, Skibo G. Brief anoxia preconditioning and HIF prolyl-hydroxylase inhibition enhances neuronal resistance in organotypic hippocampal slices on model of ischemic damage. Brain Res. 2011 Apr 22;1386:175-83. doi: 10.1016/j.brainres.2011.02.033. Epub 2011 Feb 19. PubMed PMID: 21338581. 16: Mackeen MM, Kramer HB, Chang KH, Coleman ML, Hopkinson RJ, Schofield CJ, Kessler BM. Small-molecule-based inhibition of histone demethylation in cells assessed by quantitative mass spectrometry. J Proteome Res. 2010 Aug 6;9(8):4082-4092. doi: 10.1021/pr100269b. PubMed PMID: 20583823; PubMed Central PMCID: PMC4681095. 17: Sander JR, Bucar DK, Henry RF, Baltrusaitis J, Zhang GG, MacGillivray LR. A red zwitterionic co-crystal of acetaminophen and 2,4-pyridinedicarboxylic acid. J Pharm Sci. 2010 Sep;99(9):3676-83. doi: 10.1002/jps.22229. PubMed PMID: 20574998. 18: Vlad F, Tiainen P, Owen C, Spano T, Daher FB, Oualid F, Senol NO, Vlad D, Myllyharju J, Kalaitzis P. Characterization of two carnation petal prolyl 4 hydroxylases. Physiol Plant. 2010 Oct;140(2):199-207. doi: 10.1111/j.1399-3054.2010.01390.x. PubMed PMID: 20553416. 19: Grgurić-Sipka S, Ivanović I, Rakić G, Todorović N, Gligorijević N, Radulović S, Arion VB, Keppler BK, Tesić ZLj. Ruthenium(II)-arene complexes with functionalized pyridines: synthesis, characterization and cytotoxic activity. Eur J Med Chem. 2010 Mar;45(3):1051-8. doi: 10.1016/j.ejmech.2009.11.055. Epub 2009 Dec 16. PubMed PMID: 20053483. 20: Raghunath M, Sy Wong Y, Farooq M, Ge R. Pharmacologically induced angiogenesis in transgenic zebrafish. Biochem Biophys Res Commun. 2009 Jan 23;378(4):766-71. doi: 10.1016/j.bbrc.2008.11.127. Epub 2008 Dec 7. PubMed PMID: 19068208.